First implanted in a person with a l s in august 20 19, the technology was put on a fast track review path by the fda a year later. Akin to the electrodes chang uses, the stentrode lacks the resolution of other implants so can't be used to control complex prosthetics. It allows people who cannot move or speak to control a curs on a computer tablet, and so to text, serf the internet and control connected technologies. Sincron's co founder, newologist, thomas oxley, says the company is now submitting the results of a four person feasibility trial for publication.